Deflacort 18 Tablet

About Deflacort 18 Tablet

Deflacort 18 is an 18 mg tablet made by Square Pharmaceuticals PLC. It contains deflazacort, a glucocorticoid medicine prescribed for inflammatory and immune-related conditions. Doctors use it in carefully chosen patients, and the dose and course are set by the doctor.

There are 28 brands of Deflazacort listed in Bangladesh. The lowest listed price is Dezert 6 mg Tablet at ৳ 8.00 per unit.

What is Deflacort 18 Tablet?

Deflacort 18 is a tablet form of deflazacort, a medicine belonging to the glucocorticoid group. Glucocorticoids are related to hormones the body makes naturally and are used to calm inflammation and to reduce the activity of the immune system in certain illnesses. Deflazacort works by blocking an enzyme involved in producing inflammatory substances and by reducing the release of chemicals that drive immune responses. Because it affects several body systems, Deflacort 18 is used only under medical supervision, and the doctor decides the strength and course that suit each person.

Uses of Deflacort 18

Deflacort 18 is prescribed for a range of conditions linked to inflammation or immune activity. These include severe allergic reactions and asthma, joint problems such as rheumatoid arthritis and juvenile chronic arthritis, and several connective tissue and skin conditions. It may also be used in other inflammatory disorders where a glucocorticoid is appropriate. Only a doctor can decide whether this medicine suits a particular illness; ask the doctor about the reason it has been prescribed for you.

How to use Deflacort 18

Take Deflacort 18 exactly as the doctor instructs. The doctor sets the dose and how long you take it, and this may change over time, so follow the prescription rather than deciding for yourself. Swallow the tablet as directed and do not stop it suddenly unless the doctor says so. If you miss a dose or are unsure about anything, ask your doctor or pharmacist rather than adjusting the schedule yourself.

Side effects of Deflacort 18

Deflacort 18 can cause unwanted effects because glucocorticoids act on many body systems. Reported effects include stomach and gut upset, muscle and bone problems, hormonal and metabolic changes, mood or sleep disturbances, eye problems, and fluid and salt imbalance. Some people become more prone to infection, heal more slowly, or notice skin changes such as thinning, stretch marks or acne. Tell your doctor if you notice any effect that worries you.

Safety and precautions

Deflacort 18 needs care in people with heart disease or heart failure, high blood pressure, blood clotting problems, stomach or bowel ulcers, diabetes, or a history of these conditions, and the doctor may want regular monitoring. It should not be used by anyone allergic to its ingredients or by people receiving live virus vaccines. Corticosteroids can affect pregnancy and pass into breast milk, so tell the doctor if you are pregnant, planning pregnancy or breastfeeding. Ask your doctor before starting if you have any long-term health condition or take other medicines.

Frequently asked questions

What does the tablet form and 18 mg strength mean?

Deflacort 18 comes as a tablet, a solid form you swallow with water. The 18 mg refers to the amount of deflazacort in each tablet. Your doctor decides how much you take and for how long; do not change the dose yourself.

What is Deflacort 18 used for, and what kind of medicine is it?

Deflacort 18 contains deflazacort, a glucocorticoid. It is used for inflammatory and immune-related conditions such as severe allergies, asthma, some types of arthritis and certain skin and connective tissue disorders. Your doctor can explain why it has been prescribed for you.

How should Deflacort 18 be stored?

Keep the tablets in a cool, dry place below 25°C, away from light and moisture. Store them out of the reach of children. Do not use tablets after the expiry date, and ask your pharmacist if you are unsure how to dispose of unused medicine.

Can I stop taking Deflacort 18 on my own?

No. Glucocorticoids like deflazacort should not be stopped suddenly unless your doctor tells you to. The doctor decides how the dose is reduced and when to stop. If you have problems with the medicine, speak to your doctor before making any change.

Indications

Deflazacort is indicated in-
  • Anaphylaxis, asthma, severe hypersensitivity reactions
  • Rheumatoid arthritis, juvenile chronic arthritis, polymyalgia rheumatica
  • Systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (other than systemic sclerosis), polyartritis nodosa, sarcoidosis
  • ... Read more
Deflazacort is indicated in-
  • Anaphylaxis, asthma, severe hypersensitivity reactions
  • Rheumatoid arthritis, juvenile chronic arthritis, polymyalgia rheumatica
  • Systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (other than systemic sclerosis), polyartritis nodosa, sarcoidosis
  • Pemphigus,bullous pemphigoid, pyoderma gangrenosum
  • Minimal change nephrotic syndrome, acute interstitial nephritis
  • Rheumatic carditis
  • Ulcerative colitis, Crohn's disease
  • Uveitis, optic neuritis
  • Autoimmune haemolytic anaemia, idiopathic thrombocytopenic purpura
  • Acute and lymphatic leukaemia, malignant lymphoma, multiple myeloma
  • Immune suppression in transplantation

Pharmacology

Deflazacort provides anti-inflammatory action by inhibiting Phospholipase A2 enzyme which is responsible for prostaglandin synthesis. Besides Deflazacort decreases the release of certain chemicals that are important in the immune system. By decreasing the release of these chemicals Deflazacort provides immunosuppressive action.

Dosage & Administration

Adults-
  • For acute disorders: Up to 120 mg/day Deflazacort may need to be given initially. Maintenance doses in most conditions are within the range of 3-18 mg/day.
  • Rheumatoid arthritis: The maintenance dose is usually within the range of 3-18 mg/day. The smallest effective dose should be used and increased if necessary.
  • Bronchial asthma: In the treatment of an acute attack, high doses of 48-72 mg/day may be needed depending on severity and gradually reduced once the attack has been controlled. For maintenance in chronic asthma, doses should be titrated to the lowest dose that controls symptoms.
  • Other conditions: The dose of Deflazacort depends on clinical need titrated to the lowest effective dose for maintenance. Starting doses may be estimated on the basis of ratio of 5 mg prednisone or prednisolone to 6 mg.
Children: There has been limited exposure of children to Deflazacort in clinical trials. In children, the indications for glucocorticoids arethe same as for adults, but it is important that the lowest effective dosage is used. Alternate day administration may be appropriate. Doses of Deflazacort usually lie in the range 0.25-1.5 mg/kg/day.

The following ranges provide general guidance:
  • Juvenile chronic arthritis: The usual maintenance dose is between 0.25-1.0 mg/kg/day.
  • Nephrotic syndrome: Initial dose of usually 1.5 mg/kg/day followed by down titration according to clinical need.
  • Bronchial asthma: On the basis of the potency ratio, the initial dose should be between 0.25-1.0 mg/kg on alternate days.
Deflazacort withdrawal: In patients who have received more than physiological doses of systemic corticosteroids (approximately 9 mg per day or equivalent) for greater than 3 weeks, withdrawal should not be abrupt. How dose reduction should be carried out depends largely on whether the disease is likely to relapse as the dose of systemic corticosteroids is reduced.

Interaction

Deflazacort is metabolized in the liver. It is recommended to increase the maintenance dose of Deflazacort if drugs which are liver enzyme inducers are co-administered, e.g. rifampicin, rifabutin, carbamazepine, phenobarbitone, phenytoin, primidone and aminoglutethimide. For drugs which inhibit liver enzymes, (e.g. ketoconazole) it may be possible to reduce the maintenance dose of Deflazacort.

Contraindications

Hypersensitivity to or any of the ingredients. Patients receiving live virus immunization.

Side Effects

GI disturbances, musculoskeletal, endocrine, neuropsychiatric, ophthalmic, fluid and electrolyte disturbances; susceptible to infection, impaired healing, hypersensitivity, skin atrophy, striae, telangiectasia, acne, myocardial rupture following recent Ml, thromboembolism.

Pregnancy & Lactation

Pregnancy: Deflazacort does cross the placenta. However, when administered for prolonged periods or repeatedly during pregnancy, corticosteroids may increase the risk of intrauterine growth retardation. As with all drugs, corticosteroids should only be prescribed when the benefits to the mother and child outweigh the risks.

Nursing Mother: Corticosteroids are excreted in breast milk, although no data are available for Deflazacort. Doses of up to 50 mg daily of Deflazacort are unlikely to cause systemic effects in the infant. Infants of mothers taking higher doses than this may have a degree of adrenal suppression but the benefits of breastfeeding are likely to outweigh any theoretical risk.

Precautions & Warnings

The following clinical conditions require special caution and frequent patient monitoring is necessary-
  • Cardiac disease or congestive heart failure (except in the presence of active rheumatic carditis), hypertension, thromboembolic disorders. Glucocorticoids can cause salt and water retention and increased excretion of potassium. Dietary salt restriction and potassium supplementation may be necessary.
  • Gastritis or oesophagitis, diverticulitis, ulcerative colitis if there is the probability of impending perforation, abscess or pyogenic infections, fresh intestinal anastomosis, active or latent peptic ulcer.
  • Diabetes mellitus or family history, osteoporosis, myasthenia gravis, renal insufficiency.
  • Emotional instability or psychotic tendency, epilepsy.
  • Previous corticosteroid-induced myopathy.
  • Liver failure.
  • Hypothyroidism and cirrhosis, which may increase the glucocorticoid effect.
  • Ocular herpes simplex because of possible corneal perforation.

Storage Conditions

Store in a cool (below 25°C) and dry place, protected from light & moisture. Keep out of the reach of children.

Alternative brands of Deflazacort

Other brands with the same generic name, cheapest first.

See all 28 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.